Jounce Therapeutics, Inc. [JNCE] has posted annual profit of $50.92 million for the year ended Dec 31,2022.
The company based in Massachusetts(MA)reported a risein revenue to $82 milion for the year when compared to $26.91 million in the previous year.
A filing from the company with the Securities and Exchange Commission on Mar 10,2023 showed that its revenue is up 204.75% year-over-year.
The company reported basic earnings per share of $51676.0 and diluted earnings per share of $51676.0.
Related News